Brainstorm Cell Therapeutics (BCLI) Institutional Ownership $0.76 -0.01 (-1.04%) As of 09/4/2025 02:12 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Brainstorm Cell Therapeutics (NASDAQ:BCLI)CurrentInstitutional OwnershipPercentage14.33%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$899.30KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$2.67M Get BCLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BCLI Institutional Buying and Selling by Quarter Brainstorm Cell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/24/2025 Gunderson Capital Management Inc.25,950$29K0.0%N/A0.264% 5/15/2025 Armistice Capital LLC690,666$870K0.0%N/A10.590% 2/14/2025 Two Sigma Securities LLC11,300$26K0.0%-42.9%0.198% 2/12/2025 Geode Capital Management LLC52,501$119K0.0%-92.3%0.921% 2/10/2025 Liberty Wealth Management LLC22,666$51K0.0%-93.3%0.397% 1/8/2025 Weaver Consulting Group15,623$35K0.0%-93.3%0.274% 8/15/2024 Armistice Capital LLC7,917,653$2.68M0.0%N/A11.298% 4/15/2024 Kingswood Wealth Advisors LLC81,050$46K0.0%N/A0.119% 8/14/2023 Mirador Capital Partners LP25,084$52K0.0%N/A0.064% 8/9/2023 Kingswood Wealth Advisors LLC16,600$34K0.0%N/A0.042% Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2023 Socha Financial Group LLC12,380$26K0.0%N/A0.031% 7/26/2023 Janney Montgomery Scott LLC20,000$41K0.0%N/A0.051% 7/12/2023 Professional Financial Advisors LLC17,279$36K0.0%N/A0.044% 5/15/2023 AIGH Capital Management LLC1,459,095$4.82M1.8%N/A3.978% 5/10/2023 Nelson Van Denburg & Campbell Wealth Management Group LLC12,686$42K0.0%N/A0.035% 5/3/2023 Liberty Wealth Management LLC150,400$496K0.1%N/A0.410% 4/26/2023 TRU Independence Asset Management 2 LLC44,000$145K0.1%N/A0.120% 4/14/2023Raymond James Financial Services Advisors Inc.11,248$37K0.0%N/A0.031% 4/14/2023Raymond James & Associates164,703$544K0.0%-22.6%0.449% 11/15/2022 Liberty Wealth Management LLC40,000$176K0.0%+33.3%0.110% 11/14/2022 Boothbay Fund Management LLC19,098$84K0.0%-31.5%0.052% 11/8/2022 IFP Advisors Inc28,850$151K0.0%+45.3%0.079% 11/3/2022 Creative Planning30,681$136K0.0%N/A0.084% 10/31/2022 TRU Independence Asset Management 2 LLC44,000$194K0.2%N/A0.121% 10/25/2022 Janney Montgomery Scott LLC20,000$88K0.0%N/A0.055% 10/25/2022Raymond James & Associates244,803$1.08M0.0%+30.6%0.671% 10/20/2022 Jmac Enterprises LLC40,430$179K0.1%-11.0%0.111% 10/6/2022 Abner Herrman & Brock LLC280,000$1.24M0.2%+5.7%0.767% 8/12/2022 Ikarian Capital LLC253,432$698K0.1%-16.7%0.695% 7/20/2022 Weaver Consulting Group104,653$289K0.2%-19.5%0.287% 7/11/2022S.C. Financial Services Inc.25,471$70K0.1%+66.6%0.070% 5/6/2022 Weaver Consulting Group130,000$437K0.2%-16.4%0.356% 4/7/2022 Abner Herrman & Brock LLC265,000$890K0.1%+13.7%0.726% 2/9/2022 Geneos Wealth Management Inc.10,100$40K0.0%N/A0.028% 2/8/2022 Steward Partners Investment Advisory LLC9,700$39K0.0%-42.9%0.027% 2/8/2022Raymond James & Associates189,503$758K0.0%-11.4%0.522% 2/2/2022 Aptus Capital Advisors LLC12,500$50K0.0%-21.9%0.034% 2/1/2022 Weaver Consulting Group155,500$622K0.3%+201.9%0.429% 1/26/2022S.C. Financial Services Inc.15,285$52K0.1%N/A0.042% 1/13/2022 Abner Herrman & Brock LLC233,000$932K0.1%+13.7%0.642% 11/15/2021 GSA Capital Partners LLP172,056$568K0.1%+185.6%0.474% 11/9/2021BlackRock Inc.468,967$1.55M0.0%-1.1%1.293% 10/6/2021 Abner Herrman & Brock LLC205,000$676K0.1%-15.1%0.564% 8/17/2021 Millennium Management LLC371,460$1.41M0.0%N/A1.023% 8/17/2021 Price T Rowe Associates Inc. MD93,000$353K0.0%-23.9%0.256% 8/16/2021 LMR Partners LLP11,735$45K0.0%N/A0.032% 8/16/2021 Charles Schwab Investment Management Inc.11,287$43K0.0%-85.6%0.031% 8/16/2021 State Street Corp86,703$329K0.0%-83.2%0.239% 8/16/2021Tibra Equities Europe Ltd87,000$331K0.1%N/A0.240% 8/16/2021 Goldman Sachs Group Inc.57,679$220K0.0%+144.4%0.159% 8/13/2021 Renaissance Technologies LLC47,600$181K0.0%N/A0.131% 8/13/2021 Steward Partners Investment Advisory LLC19,000$72K0.0%-38.3%0.052% 8/13/2021 Northern Trust Corp49,761$189K0.0%-83.4%0.137% 8/13/2021 Geode Capital Management LLC265,138$1.01M0.0%-44.6%0.730% 8/13/2021 Vanguard Group Inc.1,412,826$5.37M0.0%+6.2%3.890% 8/12/2021 JPMorgan Chase & Co.698,294$2.65M0.0%-13.3%1.923% 8/12/2021Ergoteles LLC124,329$472K0.0%N/A0.342% 8/11/2021 Bank of New York Mellon Corp15,899$61K0.0%-82.1%0.044% 8/11/2021BlackRock Inc.474,347$1.80M0.0%-75.7%1.306% 8/5/2021 GSA Capital Partners LLP60,238$229K0.0%+137.7%0.166% 8/2/2021 Advisor Group Holdings Inc.10,920$42K0.0%-54.5%0.030% (Data available from 1/1/2016 forward) BCLI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCLI shares? During the previous two years, the following institutional investors and hedge funds held shares of Brainstorm Cell Therapeutics shares: Armistice Capital LLC ($870K), Geode Capital Management LLC ($119K), Liberty Wealth Management LLC ($51K), Kingswood Wealth Advisors LLC ($46K), Weaver Consulting Group ($35K), and Gunderson Capital Management Inc. ($29K), and Two Sigma Securities LLC ($26K).Learn more on Brainstorm Cell Therapeutics' institutional investors. What percentage of Brainstorm Cell Therapeutics' stock is owned by institutional investors? 14.33% of Brainstorm Cell Therapeutics' stock is owned by institutional investors. Learn more on BCLI's institutional investor holdings. Which institutional investors have been buying Brainstorm Cell Therapeutics' stock? The following institutional investors have purchased Brainstorm Cell Therapeutics' stock in the last 24 months: Armistice Capital LLC ($8.61M), Kingswood Wealth Advisors LLC ($81.05K), and Gunderson Capital Management Inc. ($25.95K). How much institutional buying is happening at Brainstorm Cell Therapeutics? Institutional investors have bought a total of 716,616 shares in the last 24 months. This purchase volume represents approximately $899.30K in transactions. Which of Brainstorm Cell Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Brainstorm Cell Therapeutics stock in the last 24 months: Geode Capital Management LLC ($630.32K), Liberty Wealth Management LLC ($317.48K), Weaver Consulting Group ($218.73K), and Two Sigma Securities LLC ($8.50K). How much institutional selling is happening at Brainstorm Cell Therapeutics? Institutional investors have sold a total of 1,175,028 shares in the last 24 months. This volume of shares sold represents approximately $2.67M in transactions. Related Companies PMN Institutional Ownership SNYR Institutional Ownership TENX Institutional Ownership MIRA Institutional Ownership ASBP Institutional Ownership RLYB Institutional Ownership CVKD Institutional Ownership ENLV Institutional Ownership FBLG Institutional Ownership NAII Institutional Ownership This page (NASDAQ:BCLI) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
